Trending stocks today
Gilead Sciences Inc. (GILD-Q)
NASDAQ:GILD
92.90
0.52
(0.56%) 1d
Financials
Technical Analysis
Related posts
Tech fades in mixed tradingStocks, oil and cryptos rallyOil slides, but stocks hold on China’s weaknessThis summary was created by AI, based on 1 opinions in the last 12 months.
Experts agree that Gilead Sciences Inc., with its successful drugs for Hep C and HIV, has been a high flyer in the past. However, the impact of its own success has negatively affected the growth of these drugs. Despite this, the company still offers a decent dividend, making it an attractive option for investors.
$75.550
No
Healthcare is down 2% year. He likes the devices in HC, with Stryker his top pick. Surgeries are coming back, and the company has a new suite of products coming.
It's a biopharma which as a group did very well last year. Compare that to the smaller biotechs which have not done well the past 3 years. This year, biopharma and staples have underperformed. This boasts a high free cash flow yield and has a great product cycle coming.
Chart pattern indicating weakness in the company.
Risk lower than the past year.
$60 share price a good time to buy.
In past years, biotech was the safe trade, but this year risk is back, so these stocks have fallen out of favour. Also, there are so many drugs in trials now and big pharma needs new product. She's looking at Gilead and Moderna, because they have low PEs and alot of drugs in development. However, the overall sector is risky.
Has long owned this, because it's a value stock and keeps raising its dividend.
It is a biotech company well known for a cure for Hepatitis C which is off patent now. It made several acquisitions and has built out an HIV franchise. He needs to see execution on the oncology platform and elsewhere.
No new drugs or trials. Doing nothing interesting. Prefers Eli Lilly.
Gilead Sciences Inc.(GILD-Q) Rating
Ranking : 3 out of 5
Bullish - Buy Signals / Votes : 0
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 1
Total Signals / Votes : 1
Gilead Sciences Inc.(GILD-Q) Frequently Asked Questions
What is Gilead Sciences Inc. stock symbol?
Gilead Sciences Inc. is a American stock, trading under the symbol GILD-Q on the NASDAQ (GILD). It is usually referred to as NASDAQ:GILD or GILD-Q
Is Gilead Sciences Inc. a buy or a sell?
In the last year, 1 stock analyst published opinions about GILD-Q. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Gilead Sciences Inc..
Is Gilead Sciences Inc. a good investment or a top pick?
Gilead Sciences Inc. was recommended as a Top Pick by on . Read the latest stock experts ratings for Gilead Sciences Inc..
Why is Gilead Sciences Inc. stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Gilead Sciences Inc. worth watching?
1 stock analyst on Stockchase covered Gilead Sciences Inc. In the last year. It is a trending stock that is worth watching.
What is Gilead Sciences Inc. stock price?
On 2024-12-12, Gilead Sciences Inc. (GILD-Q) stock closed at a price of $92.9.
High flyer because of Hep C, so successful it isn't needed on an ongoing basis. Its HIV drug was equally successful. Ironically, success impacted growth of those drugs negatively. Decent dividend.